Flat Magnetic Stimulation in the Conservative Management of Mild Pelvic Organ Prolapse: A Retrospective Observational Study
<i>Background and Objectives:</i> Pelvic organ prolapse (POP) is a prevalent pelvic floor disorder affecting a large proportion of parous and aging women worldwide. While surgical intervention is generally reserved for advanced prolapse, conservative approaches remain essential for the management of early-stage disease. Flat magnetic stimulation (FMS), a novel non-invasive modality, has shown promising results in pelvic floor rehabilitation for urinary incontinence, but its role in prolapse treatment remains insufficiently investigated. This study aimed to evaluate anatomical and patient-reported outcomes in women with mild POP undergoing FMS therapy. <i>Materials and Methods:</i> This retrospective observational study included 87 women with stage ≤ 2 POP, classified according to the Pelvic Organ Prolapse Quantification (POP-Q) system. Participants underwent eight FMS sessions, each lasting 25 min, over four weeks using the Dr. Arnold device (DEKA, Calenzano, Italy). Pre- and post-treatment evaluations included standardized POP-Q measurements and the Patient Global Impression of Improvement (PGI-I) questionnaire. Statistical analyses were performed using paired <i>t</i>-tests, with significance set at <i>p</i> < 0.05. <i>Results:</i> Statistically significant improvements were observed in the anterior vaginal compartment, with mean Aa values improving from -0.3 ± 1.2 to -0.7 ± 1.3 (mean difference -0.4 cm; 95% CI -0.8 to -0.03; <i>p</i> = 0.03; Cohen's d = 0.31) and mean Ba values from -0.3 ± 1.3 to -0.7 ± 1.3 (mean difference -0.4 cm; 95% CI -0.8 to -0.02; <i>p</i> = 0.04; Cohen's d = 0.30). No significant changes were found at other POP-Q landmarks. According to PGI-I results, 90.8% of participants reported symptom improvements, and 37.9% described their condition as "very much improved" or "much improved." No adverse events occurred, and treatment compliance was 100%. <i>Conclusions:</i> FMS seems to be a safe, well-tolerated, and potentially effective conservative therapy strategy for mild POP, offering both objective anatomical benefits and high subjective satisfaction. Further randomized controlled trials with longer follow-up are required to validate these findings and clarify the long-term role of FMS in the management of pelvic floor dysfunction.
Authors
- Marta Barba (ORCID: https://orcid.org/0000-0002-7495-7185)
- Desirèe De Vicari (ORCID: https://orcid.org/0009-0001-9149-1081)
- Matteo Frigerio (ORCID: https://orcid.org/0000-0003-3952-8462)
- Silvia Carrara (ORCID: https://orcid.org/0000-0003-4206-9463)
- Alice Cola (ORCID: https://orcid.org/0000-0003-1071-152X)
- Nicola Amatucci (ORCID: https://orcid.org/0009-0006-1820-0205)
Institutions
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- Medicina
- Published
- 2025-12-11
- DOI
- https://doi.org/10.3390/medicina61122198
- Primary Topic
- Pelvic floor disorders treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00